Cargando…
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
BACKGROUND: Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. FRG1 which affects angiogenesis and cel...
Autores principales: | Tiwari, Ankit, Mukherjee, Bratati, Hassan, Md. Khurshidul, Pattanaik, Niharika, Jaiswal, Archita Mohanty, Dixit, Manjusha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458714/ https://www.ncbi.nlm.nih.gov/pubmed/30975102 http://dx.doi.org/10.1186/s12885-019-5509-4 |
Ejemplares similares
-
Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
por: Mukherjee, Bratati, et al.
Publicado: (2022) -
Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors
por: Tiwari, Ankit, et al.
Publicado: (2017) -
Reduced FRG1 expression promotes angiogenesis via activation of the FGF2‐mediated ERK/AKT pathway
por: Mukherjee, Bratati, et al.
Publicado: (2023) -
Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status
por: Kumar, Dinesh, et al.
Publicado: (2021) -
Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers
por: Kumar, Dinesh, et al.
Publicado: (2017)